DNA modification study of major depressive disorder: beyond locus-by-locus comparisons.

TitleDNA modification study of major depressive disorder: beyond locus-by-locus comparisons.
Publication TypeJournal Article
Year of Publication2015
AuthorsOh G, Wang S-C, Pal M, Chen ZFei, Khare T, Tochigi M, Ng C, Yang YA, Kwan A, Kaminsky ZA, Mill J, Gunasinghe C, Tackett JL, Gottesman II, Willemsen G, de Geus EJC, Vink JM, P Slagboom E, Wray NR, Heath AC, Montgomery GW, Turecki G, Martin NG, Boomsma DI, McGuffin P, Kustra R, Petronis A
JournalBiol Psychiatry
Volume77
Issue3
Pagination246-55
Date Published2015 Feb 1
ISSN1873-2402
KeywordsAdolescent, Adult, Aged, CpG Islands, Depressive Disorder, Major, Epigenesis, Genetic, Female, Humans, Leukocytes, Male, Microarray Analysis, Middle Aged, Prefrontal Cortex, Spermatozoa, Twins, Monozygotic, Young Adult
Abstract

BACKGROUND: Major depressive disorder (MDD) exhibits numerous clinical and molecular features that are consistent with putative epigenetic misregulation. Despite growing interest in epigenetic studies of psychiatric diseases, the methodologies guiding such studies have not been well defined.METHODS: We performed DNA modification analysis in white blood cells from monozygotic twins discordant for MDD, in brain prefrontal cortex, and germline (sperm) samples from affected individuals and control subjects (total N = 304) using 8.1K CpG island microarrays and fine mapping. In addition to the traditional locus-by-locus comparisons, we explored the potential of new analytical approaches in epigenomic studies.RESULTS: In the microarray experiment, we detected a number of nominally significant DNA modification differences in MDD and validated selected targets using bisulfite pyrosequencing. Some MDD epigenetic changes, however, overlapped across brain, blood, and sperm more often than expected by chance. We also demonstrated that stratification for disease severity and age may increase the statistical power of epimutation detection. Finally, a series of new analytical approaches, such as DNA modification networks and machine-learning algorithms using binary and quantitative depression phenotypes, provided additional insights on the epigenetic contributions to MDD.CONCLUSIONS: Mapping epigenetic differences in MDD (and other psychiatric diseases) is a complex task. However, combining traditional and innovative analytical strategies may lead to identification of disease-specific etiopathogenic epimutations.

DOI10.1016/j.biopsych.2014.06.016
Alternate JournalBiol. Psychiatry
PubMed ID25108803
PubMed Central IDPMC4277915
Grant List77689 / / Canadian Institutes of Health Research / Canada
AA07535 / AA / NIAAA NIH HHS / United States
AA07728 / AA / NIAAA NIH HHS / United States
MH074127 / MH / NIMH NIH HHS / United States
MH088413 / MH / NIMH NIH HHS / United States
R01 MH074127 / MH / NIMH NIH HHS / United States
R01 MH088413 / MH / NIMH NIH HHS / United States

  • Douglas Hospital
  • Dobell Pavillion
  • Brain imaging centre